Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
帕妥珠单抗联合曲妥珠单抗生物类似药SB3双重抑制治疗HER2阳性乳腺癌患者的安全性和临床评价
期刊:Breast Care
影响因子:2.1
doi:10.1159/000513766
Suppan, Christoph; Steiner, Daniel; Klocker, Eva Valentina; Posch, Florian; Henzinger, Elisabeth; Müller, Hannah Deborah; Stöger, Herbert; Dandachi, Nadia; Balic, Marija